Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Redesign of EAF Peg Hb As an Oxygen Transfer Catalyst for Improved Tissue Oxygenation of Hypoxic Areas: A Therapeutic for Anemia and Sickle Cell Disease

Savita Bhutoria, PhD, Amy Tsai, PhD, Marcos Intaglietta, PhD, Sandra M. Suzuka, MS, Sangeetha Thangaswamy, PhD, Prabhakaran Muthuchidambaram, PhD, Caterina Minniti, MD, Henny Heisler H Billett, MD, Craig A Branch, PhD, Seetharama A Acharya, PhD

Blood (2016) 128 (22): 4845.

https://doi.org/10.1182/blood.V128.22.4845.4845

Published: 2016

Journal Articles

Therapeutic Activity of Peg Albumin in Transgenic Mouse Model of Sickle Cell Disease Is a Function of the Pattern of Pegylation

Devendra Lingojwar, PhD, Savita Bhutoria, PhD, Fantao Meng, PhD, Sangeetha Thangaswamy, PhD, Henny H Billett, MD, Caterina Minniti, MD, Amy Tsai, PhD, Marcos Intaglietta, PhD, Craig A Branch, PhD, Seetharama A Acharya, PhD

Blood (2016) 128 (22): 4848.

https://doi.org/10.1182/blood.V128.22.4848.4848

Published: 2016

Journal Articles

Thiocarbmoylation Chemistry Based Pegylation Of αα Fumaryl-Hb Is Unique As It Does Not Induce An Increase In Oxygen Affinity: High Oxygen Affinity Pegylated Crosslinked Hbs Are Better As Oxygen Therapeutics

Fantao Meng, PhD, Amy Tsai, PhD, Marcos Intaglietta, PhD, Seetharama A. Acharya, PhD

Blood (2013) 122 (21): 1164.

https://doi.org/10.1182/blood.V122.21.1164.1164

Published: 2013

Journal Articles

Dissociation of local nitric oxide concentration and vasoconstriction in the presence of cell-free hemoglobin oxygen carriers

Amy G. Tsai, Pedro Cabrales, Belur N. Manjula, Seetharama A. Acharya, Robert M. Winslow, Marcos Intaglietta

Blood (2006) 108 (10): 3603–3610.

https://doi.org/10.1182/blood-2006-02-005272

Published: 2006

Journal Articles

MP4, a Human Hemoglobin Modified with Maleimide-Peg, Reduces Sickling of Red Blood Cells in an In Vitro Model.

Robert Winslow, MD, Mariana Oliva, Marcos Intaglietta, PhD, Kim Vandegriff, PhD, Dale Baker, PhD, Ashok Malavalli

Blood (2005) 106 (11): 3798.

https://doi.org/10.1182/blood.V106.11.3798.3798

Published: 2005

NARROW

Redesign of EAF Peg Hb As an Oxygen Transfer Catalyst for Improved Tissue Oxygenation of Hypoxic Areas: A Therapeutic for Anemia and Sickle Cell Disease

Therapeutic Activity of Peg Albumin in Transgenic Mouse Model of Sickle Cell Disease Is a Function of the Pattern of Pegylation

Thiocarbmoylation Chemistry Based Pegylation Of αα Fumaryl-Hb Is Unique As It Does Not Induce An Increase In Oxygen Affinity: High Oxygen Affinity Pegylated Crosslinked Hbs Are Better As Oxygen Therapeutics

Dissociation of local nitric oxide concentration and vasoconstriction in the presence of cell-free hemoglobin oxygen carriers

MP4, a Human Hemoglobin Modified with Maleimide-Peg, Reduces Sickling of Red Blood Cells in an In Vitro Model.

Email alerts

ASH Publications

American Society of Hematology

Redesign of EAF Peg Hb As an Oxygen Transfer Catalyst for Improved Tissue Oxygenation of Hypoxic Areas: A Therapeutic for Anemia and Sickle Cell Disease

Therapeutic Activity of Peg Albumin in Transgenic Mouse Model of Sickle Cell Disease Is a Function of the Pattern of Pegylation

Thiocarbmoylation Chemistry Based Pegylation Of αα Fumaryl-Hb Is Unique As It Does Not Induce An Increase In Oxygen Affinity: High Oxygen Affinity Pegylated Crosslinked Hbs Are Better As Oxygen Therapeutics

Dissociation of local nitric oxide concentration and vasoconstriction in the presence of cell-free hemoglobin oxygen carriers

MP4, a Human Hemoglobin Modified with Maleimide-Peg, Reduces Sickling of Red Blood Cells in an In Vitro Model.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only